Perioperative Management of Patients with Cardiovascular Conditions
Introduction to Risks
- Patients with atrial fibrillation, heart failure, and diabetes have a high-risk profile for perioperative complications, including increased mortality and morbidity, and require optimized heart failure management and adequate rate control of atrial fibrillation before surgery, as recommended by the European Heart Journal and the American College of Cardiology 1, 2
- Diabetes is an independent risk factor that increases perioperative complications, including perioperative hemodynamic instability, as stated by Anaesthesia 3
- Anticoagulation management presents additional perioperative challenges in patients with atrial fibrillation, according to the American College of Cardiology 2
Cardiovascular Risk Factors
- The combination of atrial fibrillation, heart failure, and diabetes creates a high-risk profile, with multiple factors in the CHADS2 score (Congestive heart failure, Hypertension, Age ≥75, Diabetes, prior Stroke), as noted by the European Heart Journal 1
- Interruption of anticoagulation increases thromboembolic risk, while continuing anticoagulation increases bleeding risk, as stated by the American College of Cardiology 2
Perioperative Complications
- Diabetic patients have higher rates of perioperative hemodynamic instability, and the combination of atrial fibrillation, heart failure, and diabetes significantly increases the risk of heart failure exacerbation, stroke, myocardial infarction, and bleeding complications, according to the European Heart Journal and Anaesthesia 1, 3
Preoperative Optimization
- Optimizing heart failure management with appropriate medications, diabetes management, and ensuring adequate rate control of atrial fibrillation before surgery are recommended by the European Heart Journal, Anaesthesia, and the American College of Cardiology to reduce perioperative complications 1, 2, 3
Postoperative Care
- Patients with atrial fibrillation, heart failure, and diabetes require comprehensive preoperative cardiac evaluation, perioperative monitoring in a higher-level care setting, and extended postoperative monitoring for at least 48-72 hours, as stated by the American College of Cardiology 2
- A preoperative 12-lead ECG is recommended for patients with known coronary heart disease undergoing intermediate-risk procedures, serving as an important baseline for comparison if postoperative complications develop, as per the American Heart Association 4, 5
- Clinical assessment of functional status, including evaluation of exercise capacity and assessment for new or changed cardiac symptoms, is crucial in patients with complex coronary artery disease history 4
- Basic laboratory tests, such as complete blood count, basic metabolic panel, and coagulation studies, are recommended for patients undergoing noncardiac surgery 4
- The following are not recommended unless specific conditions are met:
- Antiplatelet management should be discussed with the surgical team, and aspirin should be continued if possible for patients with coronary stents, as recommended by the American Heart Association 6
- Perioperative beta-blockade should be considered for patients already on beta-blockers, but not recommended to start acutely before surgery, according to the American College of Cardiology 7
- Medication reconciliation, including review and optimization of all cardiac medications, is essential to ensure continuation of appropriate medical therapy for coronary artery disease 4
- Postoperative monitoring, including continuous telemetry and daily ECGs, is recommended for patients with complex cardiac history, along with early mobilization to reduce thrombotic risk and optimization of secondary prevention, as stated by the American Heart Association and the American College of Cardiology 4